Vaccine testing for Covid-19 has started in Europe. Nine volunteers of 800 expected were injected with the Vaccine Thursday in the Oxford University Hospital.
The University is also considering the same Vaccine trials in Kenya, where the rates of transmission are growing from a lower base. Prof Sarah Gilbert, the team leader says the rate of the transmission in Kenya has attracted their attention to conduct trials, anticipating a rate thread of reasons in Africa.
The test is expected to be run on more that 800 people recruited for the study across the different European Countries. Half of these are expected to receive the Covid-19 Vaccine, while the other half will receive another Vaccine that protects against meningitis but not corona virus.
The vaccine has been developed within three months by a team of pre-clinical researchers at Oxford University led by Prof. Sarah Gilbert at the Jenner Institute.
The team is prioritizing the enrollment of local healthcare workers into the trial as they are more likely than others to be exposed to the virus. Older people tend to have weaker immune responses to vaccines. Researchers are evaluating whether they might need two doses of the jab.
How safe is the Vaccine?
The trial volunteers have been warned of mild irritations and visible body defects like sore arms, headaches or fever in the first couple of days. They have also been told of a theoretical risk that the virus could induce a serious reaction to coronavirus, which arose in some early Sars animal vaccine studies
Scientists hope to have one million doses ready by September, and to dramatically scale up manufacturing after that, should the vaccine prove effective.